Quarterly ResultAug 11, 2026, 07:17 AM

Kardigan Q2 Net Loss $116.2M; IPO Raises $422.4M

AI Summary

Kardigan, Inc. reported a net loss of $116.2 million for the second quarter of 2026, an increase from $57.4 million in the same period last year. For the six months ended June 30, 2026, the net loss was $172.3 million. The company successfully completed its Initial Public Offering (IPO) on June 22, 2026, generating net proceeds of $422.4 million, which significantly boosted its cash position and alleviated prior concerns about its ability to continue as a going concern.

Key Highlights

Net loss for Q2 2026 was $116.2 million, compared to $57.4 million in Q2 2025.
Net loss for the six months ended June 30, 2026, was $172.3 million, up from $75.4 million in 2025.
Cash and cash equivalents increased to $384.0 million as of June 30, 2026, from $109.0 million at December 31, 2025.
Total assets grew to $721.8 million as of June 30, 2026, from $390.9 million at December 31, 2025.
Total stockholders' equity (deficit) improved to $615.5 million from a deficit of $250.3 million.
Research and development expenses for Q2 2026 were $56.4 million, up from $35.8 million in Q2 2025.
The company completed its IPO on June 22, 2026, receiving net proceeds of $422.4 million.

View SEC Filing

KARD

Pharmaceutical Preparations

Kardigan, Inc.

Price Impact